Desarrollo de un programa piloto de farmacovigilancia en el hospital San Juan de Dios de Zipaquirá
Pharmacovigilance hospital programs play a key role in the consolidation of a national program and the continuous improvement of health care. The goal of this study was to develop a pharmacovigilance pilot program in a level two hospital and identify the salient clinical features of the adverse reac...
- Autores:
-
Tribiño E., Gabriel
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2008
- Institución:
- Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
- Repositorio:
- Repositorio Institucional UDCA
- Idioma:
- spa
- OAI Identifier:
- oai:repository.udca.edu.co:11158/2679
- Acceso en línea:
- https://revistas.udca.edu.co/index.php/ruadc/article/view/623
https://doi.org/10.31910/rudca.v11.n2.2008.623
- Palabra clave:
- Farmacología - Efectos adversos
Farmacoepidemiología
Efectos adversos
Vigilancia epidemiológica
Proyectos piloto
Hospitales
- Rights
- openAccess
- License
- Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales
Summary: | Pharmacovigilance hospital programs play a key role in the consolidation of a national program and the continuous improvement of health care. The goal of this study was to develop a pharmacovigilance pilot program in a level two hospital and identify the salient clinical features of the adverse reactions detected. The program was presented before the hospital’s Epidemiologic Surveillance Committee and the professionals of the wards included (internal medicine, surgery, obstetrics and gynecology and emergency). Information was collected by spontaneous reporting by the medical staff and intensive follow-up, carried out by the researcher during a six month period (march-september 2006). A format based on the INVIMA reporting sheet was used. Reports presented periodically to the committee were produced. Sixty adverse drug reactions were detected, of which 48 occurred in hospitalized patients (incidence 19X1000); eight led to hospitalization and four were detected in the emergency ward. Adverse reactions affecting gastrointestinal system were the most frequent ones reported in hospitalized patients (27%). Hypoglycemia was the adverse reaction that more often led to hospitalization (62.5%). 82% of the adverse reactions were reported by the author and 18% by the medical staff. Some of the clinical features of the adverse reactions detected are similar to those found in studies performed at level three hospitals. The rate of spontaneous notification was low. The features of the program match those of a second level hospital and allow its continuity. |
---|